z-logo
open-access-imgOpen Access
High prevalence and long duration of nervous system and psychiatric adverse drug reactions in Ugandan patients taking efavirenz 600 mg daily
Author(s) -
Kay Seden,
Daniel Kiiza,
Eva Laker,
Walter Joseph Arinaitwe,
Catriona Waitt,
Mohammed Lamorde,
Saye Khoo
Publication year - 2018
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dky298
Subject(s) - efavirenz , medicine , adverse effect , drug , drug reaction , psychiatry , duration (music) , pediatrics , human immunodeficiency virus (hiv) , virology , antiretroviral therapy , viral load , art , literature
Efavirenz-related nervous system or psychiatric adverse drug reactions (ADRs) are conventionally reported to resolve soon after initiation, with incidence of dizziness at 8.5% in large clinical trials. Patients of black ethnicity are genetically at greater risk of elevated efavirenz exposure, which has been linked to nervous system toxicity.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom